Comparative Dosing of Adjunctive Corticosteroids Therapy for Pneumocystis Pneumonia with ARDS in Non-HIV Immunocompromised Patients
Xuyan Li, Lujia Guan, Dong Wang, Xiao Tang, Rui Wang, Ying Li, Zhaohui Tong, Bing Sun, Chen Wang · 2024
Read Comparative Dosing of Adjunctive Corticosteroids Therapy for Pneumocystis Pneumonia with ARDS in Non-HIV Immunocompromised Patients by Xuyan Li, Lujia Guan, Dong Wang, Xiao Tang, Rui Wang, Ying Li, Zhaohui Tong, Bing Sun, Chen Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646425.txt.
Description
Xuyan Li and co-authors published this lung study in 2024. Pneumocystis pneumonia can flood the lungs of people with weak immune systems, and in this study none of the patients had HIV. Steroids help HIV-linked cases, but their best dose here was in doubt. The team looked back at 105 such patients with severe lung failure at a Beijing hospital, from 2015 to 2022.
Half got standard-dose steroids and half got low doses. By sixty days, deaths ran lower in the standard-dose group. After weighing other traits, the standard dose cut the risk of death at both one and two months. Gains were clearest in younger patients, non-smokers, and those on breathing machines. Extra infections and gut bleeding did not rise. The authors back the standard dose for such cases, while noting the study was not a randomized trial.
Catalog record
| CREATOR | Xuyan Li, Lujia Guan, Dong Wang, Xiao Tang, Rui Wang, Ying Li, Zhaohui Tong, Bing Sun, Chen Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |